Matches in Nanopublications for { ?s ?p "[The most common inactivation mechanism of RASSF1A is promoter hypermethylation, which is observed in multiple solid tumors including lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP686414.RApjKe8ZQQr8yVYM6YK3N6fkiEGODGSV2XMfvSBEaJvdc130_assertion description "[The most common inactivation mechanism of RASSF1A is promoter hypermethylation, which is observed in multiple solid tumors including lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP686414.RApjKe8ZQQr8yVYM6YK3N6fkiEGODGSV2XMfvSBEaJvdc130_provenance.
- assertion description "[The most common inactivation mechanism of RASSF1A is promoter hypermethylation, which is observed in multiple solid tumors including lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP591637.RAih1E4ovfEuPTMr-9WXCXEFWjTy1xsnE-SMY27QPC7Kk130_assertion description "[The most common inactivation mechanism of RASSF1A is promoter hypermethylation, which is observed in multiple solid tumors including lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591637.RAih1E4ovfEuPTMr-9WXCXEFWjTy1xsnE-SMY27QPC7Kk130_provenance.
- NP862064.RA-KdpvhjuCmTezTwbTL7n5rnmEzOQ4B-1HEN_aT4p4_Y130_assertion description "[The most common inactivation mechanism of RASSF1A is promoter hypermethylation, which is observed in multiple solid tumors including lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862064.RA-KdpvhjuCmTezTwbTL7n5rnmEzOQ4B-1HEN_aT4p4_Y130_provenance.